Sepsis & infection

Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis

Crit CarePublished Systematic review and meta-analysis of observational studies and randomised controlled trials

Pooled result · 28-day mortalityResult — go to the resultOdds ratio 0.53 95% CI 0.36–0.77

Authors' conclusion

The treatment with the oXiris filter during CRRT in sepsis patients may be associated with lower 28-, 7-, and 14-day mortalities, lactate levels, SOFA score, NE dose, and shorter length of ICU stay.

Study context

Population
Patients with sepsis receiving continuous renal replacement therapy (CRRT)
Participants
695 patients · 14 studies
Comparison
CRRT with oXiris filter vs other filters
Outcome
28-day mortality
Follow-up
28 days
Methodological detailsGrading of Recommendations, Assessment, Development, and Evaluation (GRADE) certainty assessment, 10 observational studies of intermediate to high quality (average Newcastle-Ottawa score 7.8); all 4 randomized controlled trials (RCTs) unclear risk of bias
  • GRADE certainty assessment
  • 10 observational studies of intermediate to high quality (average Newcastle-Ottawa score 7.8); all 4 RCTs unclear risk of bias

Pooled result

As reported in the abstract

Odds ratio

0.53

95% CI 0.36–0.77

P = 0.001

oXiris vs Other filters
OR 0.53 (95% CI 0.36–0.77); P = 0.001

Further pooled results

OutcomeWeighted mean difference (95% CI)P value
ICU LOS- 1.91 (- 2.56 to - 1.26)P < 0.001

Sequential Organ Failure Assessment (SOFA) score, norepinephrine (NE) dose, IL-6 and lactate levels, 7- and 14-day mortality

Lower in the oXiris group

90-day mortality, intensive care unit (ICU) and hospital mortality, hospital LOS

Comparable

Original publication

Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis. Crit Care. Published 9 July 2023. doi:10.1186/s13054-023-04555-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.